Skip to main content

TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas

FORT23/00034

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Fortalecimiento Institucional
Call Programa FORTALECE
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of valve-sparing aortic root replacement on aortic fluid dynamics and biomechanics in patients with syndromic heritable thoracic aortic disease

  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Ruiz Muñoz, Aroa|||0000-0002-1138-8528
  • Guala, Andrea|||0000-0002-5006-8164
  • Galian-Gay, Laura|||0000-0001-6828-5928
  • Fernandez-Galera, Rubén
  • Valente, Filipa|||0000-0002-5569-3292
  • Casas, Guillem|||0000-0001-7122-320X
  • Oliveró, Ruperto|||0000-0002-0888-8572
  • Ferrer-Cornet, Marta
  • Bragulat-Arévalo, Mireia
  • Carrasco-Poves, Alejandro
  • Garrido-Oliver, Juan|||0000-0002-5806-2031
  • Morales-Galán, Alberto
  • Johnson, Kevin M.
  • Wieben, Oliver
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Rodriguez-Palomares, José F
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
Patients with syndromic heritable thoracic aortic diseases (sHTAD) who underwent prophylactic aortic root replacement are at high risk of distal aortic events, but the underlying mechanisms remain unclear. This prospective, longitudinal study evaluates the impact of valve-sparing aortic root replacement (VSARR) on aortic fluid dynamics and biomechanics in these patients. Sixteen patients with Marfan or Loeys-Dietz syndrome underwent two time-resolved three-dimensional phase-contrast cardiovascular magnetic resonance (4D flow CMR) studies before (sHTAD-preSx) and after VSARR (sHTAD-postSx). Two matched cohorts of 40 healthy volunteers (HV) and 16 sHTAD patients without indication for aortic root replacement (sHTAD-NSx) with available 4D flow CMR were included for comparison. In-plane rotational flow (IRF), systolic flow reversal ratio (SFRR), wall shear stress (WSS), pulse wave velocity (PWV), and aortic strain were analyzed in the ascending (AscAo) and descending aorta (DescAo). All patients with sHTAD presented altered hemodynamics and increased stiffness (p < 0.05) compared to HV, both in the AscAo (median PWV 7.4 in sHTAD-NSx; 6.8 in sHTAD-preSx; 4.9 m/s in HV) and DescAo (median PWV 9.1 in sHTAD-NSx; 8.1 in sHTAD-preSx; 6.3 m/s in HV). Patients awaiting VSARR had markedly reduced in-plane (median IRF -2.2 vs 10.4 cm 2 /s in HV, p = 0.001), but increased through-plane flow rotation (median SFRR 7.8 vs 3.8% in HV, p = 0.002), and decreased WSS (0.36 vs 0.47 N/m 2 in HV, p = 0.004) in the proximal DescAo. After VSARR, proximal DescAo IRF (p = 0.010) and circumferential WSS increased (p = 0.011), no longer differing from HV, but SFRR, axial WSS and stiffness remained altered. Patients in which aortic tortuosity was reduced after surgery showed greater post-surgical increase in IRF compared to those in which tortuosity increased (median IRF increase 18.1 vs 3.3 cm 2 /s, p = 0.047). Most AscAo flow alterations were restored to physiological values after VSARR. In patients with sHTAD, VSARR partially restores downstream fluid dynamics to physiological levels. However, some flow disturbances and increased stiffness persist in the proximal DescAo. Further longitudinal studies are needed to evaluate whether persistent alterations contribute to post-surgical risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Case of Hyperinsulinemic Hypoglycaemia Associated with Atypical Fanconi Renal Tubulopathy Syndrome Caused by an HNF4A Variant

  • Garriga-Edo, Sarai
  • Peris-Serra, Lydia
  • Ríos Duro, Héctor
  • Giralt, Marina
  • Díaz-Troyano, Noelia|||0000-0002-9392-0142
  • Ferrer, Roser
  • Ferrer, Roser
  • Antolín, María|||0000-0001-5623-6862
  • Pérez Dueñas, Belén
  • Clemente, Maria|||0000-0002-3721-5043
Introduction: This case illustrates the challenges in the diagnosis of a rare disease with an intricate orientation. The definitive genetic diagnosis was carried out after establishing crucial correlations between the preliminary clinical indications and the laboratory findings. Case Presentation: The initial presentation was myoclonic jerks. This was a direct consequence of hyperinsulinaemic hypoglycaemia (HH), and not a phenotypic characteristic described in previous case reports. Linking this to glycaemia led to the evaluation of response to fasting, where inadequate insulin suppression resulted in hypoketotic hypoglycaemia. The diagnosis of chronic kidney dysfunction associated with atypical Fanconi renal tubulopathy syndrome type 4 (FRTS4) was indicated on the basis of a decreased estimated glomerular filtration rate, nephrocalcinosis, millimetric lithiasis, rickets, and complex proximal tubulopathy. This indicated atypical FRTS4 as associated with HH and necessitated further molecular genetic testing. Conclusion: The patient was identified as a carrier of the c.187C>T (p.Arg63Trp) variant in the HNF4A gene, which is a heterozygous missense variant classified as pathogenic. This entity is rare, and the published literature reporting HNF4A gene variants associated with atypical FRTS and HH is limited. It is therefore important to report such cases to contribute to the growing body of evidence and help identify pathogenic HNF4A variants and their implications.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy

  • Zhao, Xuesong
  • Hao, Qianyun
  • Acosta, Daniel
  • Terán-Brage, Eduardo
  • Macarulla, Teresa
  • Alsina, Maria
  • Castet, Florian
  • Vega, kreina
  • Castro Boix, Sandra
  • TIAN, TIAN
Asia-West disparities; Chemotherapy; Gastric cancer, Disparidades entre Asia y Occidente; Quimioterapia; Cáncer gástrico, Disparitats entre Àsia i Occident; Quimioteràpia; Càncer gàstric, Gastric cancer (GC) remains a significant global health burden. Both Asian countries and Western nations, represented by Europe and North America, have long been pioneers in GC research and continue to lead advancements in the field. However, notable differences have historically existed between these regions in the treatment of resectable GC. In recent years, increasing convergence between Asian and Western approaches has emerged, driven by the growth of global collaborative studies. New definitive evidence suggests that the therapeutic landscape for resectable GC may undergo a significant transformation. In this review, we comprehensively examine the evolution of surgical approaches and perioperative chemotherapy strategies in Asia and the West. We summarize key clinical trials, highlight persistent survival disparities, and provide insight into current trends in perioperative management, including the recent advances in molecularly driven perioperative treatments. Finally, we outline key considerations for future multicenter perioperative trials to further guide global clinical practice., X.Z. is supported by grants from the Peking University People's Hospital (RDJP2024-20). T.V.T. is supported by grants from the Spanish Ministry of Science, Innovation, and Universities (PID2023-146827OB-I00), the “Ramon y Cajal” program (RYC2020-029098-I), and the FERO Foundation. T.M. is supported by grants from the Spanish Institute of Carlos III (PI20/00898, PI24/00526, FORT23/00034), EU TRANSCAN-3, and PerMed projects.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis

  • Conti, Sefora
  • Basagana, Míriam
  • Pando Rau, Elizabeth
  • Caritá, Lorenzo
  • Villacampa Javierre, Guillermo
  • Tissera, Natalia Soledad
  • Castet, Florian
  • Salcedo, Maria-Teresa
  • DOPAZO, CRISTINA
  • Navarro Garces, Victor
  • TIAN, TIAN
  • Macarulla, Teresa
Anatomic location; Cholangiocarcinoma; Disease-free survival, Localització anatòmica; Colangiocarcinoma; Supervivència lliure de malaltia, Localización anatómica; Colangiocarcinoma; Supervivencia libre de enfermedad, Background & Aims Cholangiocarcinoma (CCA), a heterogeneous malignancy that includes intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes, often exhibits perineural invasion (PNI). Despite PNI being associated with postoperative recurrence, evidence on its prognostic impact remains inconsistent. To clarify this, we conducted a systematic review and meta-analysis. Methods A comprehensive literature search was conducted across the Medline-PubMed, Embase, and Web of Science databases from their inception through February 27, 2025. We included studies involving patients diagnosed with CCA who underwent surgery and for whom PNI data were available. The primary outcomes were overall survival (OS) and disease-free survival (DFS), extracted from both univariable and multivariable analyses. The study is registered in PROSPERO (CRD42024575458). Results Of 1,555 articles screened, 64 retrospective studies comprising 15,543 patients were included. In the univariable analysis, the pooled hazard ratio (HR) for OS from 34 studies (6,084 patients) was 1.92 (95% CI 1.67-2.21, I2 = 59.6%). Multivariable-adjusted analysis of 42 studies (10,335 patients) showed an HR of 1.68 (95% CI 1.47-1.90, I2 = 47.9%) for patients with PNI. For DFS, the pooled univariable HR in 6,110 patients was 1.70 (95% CI 1.46-1.98, I2 = 52.3%), and the multivariable HR was 1.62 (95% CI 1.37-1.92, I2 = 70.5%)). Prognostic consistency was observed across anatomical subgroups. Univariable OS HRs were 2.14 for iCCA, 1.69 for pCCA, and 1.66 for dCCA. Corresponding multivariable HRs were 1.74, 1.60, and 1.66, respectively. Conclusions PNI is a prognostic factor for both DFS and OS in CCA, regardless of anatomical location. Further research is needed to elucidate its biological mechanisms and potential therapeutic implications. Impact and implications This comprehensive review and meta-analysis confirms that perineural invasion (PNI) predicts poorer overall and disease-free survival in cholangiocarcinoma, independent of tumor location. These results highlight the potential of PNI as a reliable histopathological marker to stratify postoperative risk and inform patient management. While most evidence is retrospective and smaller studies may overstate the effect, the consistent findings emphasize the need for large, multicenter prospective studies with standardized pathological assessment. Such efforts could facilitate the integration of PNI into prognostic models and support more individualized treatment strategies for patients with cholangiocarcinoma., S.C. is supported by a Juan de la Cierva Fellowship from the Spanish Ministry of Science, Innovation and Universities (JDC2023-050981-I). N.T. is supported by a La Pedrera MD-PhD fellowship from the Fundació Catalunya La Pedrera. T.M. is supported by grants from the Spanish Institute of Carlos III (PI20/00898, PI24/00526, FORT23/00034), EU TRANSCAN-3, and PerMed projects. T.V.T. is supported by grants from the Spanish Ministry of Science, Innovation and Universities (PID2023-146827OB-I00), “Ramon y Cajal” program (RYC2020-029098-I), FERO Foundation, Fundación AstraZeneca “Jóvenes Investigadores” program, and Cancer Core Europe TRYTRAC program.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

  • Maas, Silvana C.E.
  • Lemler, Lea
  • Butjosa, Maria
  • Blanco Irazuegui, Odei
  • Seoane, Jose A.
  • Baraibar, Iosune
  • Tabernero, Josep
  • Elez, Elena
Epigenetic fingerprints; Colon and rectal cancer; Pesticide exposure, Empremtes digitals epigenètiques; Càncer de còlon i recte; Exposició a pesticides, Huellas digitales epigenéticas; Cáncer de colon y recto; Exposición a pesticidas, The incidence of colorectal cancer (CRC) is rising rapidly in people younger than 50 years. Although this increase parallels shifts in lifestyle and environmental factors—collectively termed the exposome—whether these are indeed linked to the development of early-onset CRC (EOCRC) remains uninvestigated. Due to limited exposome data in most cancer cohorts, we constructed weighted methylation risk scores as proxies for exposome exposure to pinpoint specific risk factors associated with EOCRC compared to late-onset CRC (LOCRC) patients diagnosed at ≥70 years. Our analysis confirmed previously identified risk factors, including educational attainment, diet and smoking habits. Moreover, we identified exposure to the herbicide picloram as a new risk factor (adjusted P = 4.4 × 10−4) in the discovery cohort (31 EOCRC versus 100 LOCRC), which was replicated in a meta-analysis comprising nine CRC cohorts (P = 3.1 × 10−3; adjusted P = 1.5 × 10−2; 83 EOCRC versus 272 LOCRC). Subsequently, we analyzed population-based data from 94 US counties over 21 years and validated the association between picloram use and EOCRC incidence (P = 4.52 × 10−4), which remained significant after adjusting for socioeconomic factors and other pesticide use. These findings highlight the critical role of the exposome in EOCRC risk, underscoring the urgency for targeted personal and policy-level interventions., First and foremost, we thank the participants and their families who took part in the studies analyzed. We are grateful to the investigators and data management teams who recruited the participants and to the pathologists who collected the samples. We thank J. Carmona and members of the Cancer Computational Biology Group for the helpful discussions. The results shown here are based, in part, on data generated by the TCGA Research Network (https://www.cancer.gov/tcga) and the SEER Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER Plus Research Data, 8 Registries, November 2021 submission (1975–2019)—Linked To County Attributes based on the November 2021 submission. This research was funded by the Instituto de Salud Carlos III (FORT23/00034), cofinanced by the European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future.’ Grants CMS2022-135428, RYC2019-026576-I (to J.A.S.), JDC2022-048829-I (to S.C.E.M.) and FPU22/03520 (to M.B.E.) funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by ‘ESF Investing in your future,’ by ESF+ or by European Union NextGenerationEU/PRTR. Grant PID2020-115097RA-I00 funded by MICIU/AEI/ 10.13039/501100011033 (to J.A.S.) and, as appropriate, by ‘ERDF A way of making Europe,’ by ERDF/EU, by the European Union or by the European Union NextGenerationEU/PRTR and Ayuda Postdoctoral AECC POSTD258824MAAS (to S.C.E.M.). The research leading to these results has received funding from la Caixa Foundation. This work was supported by the VHIO-CRIS Program for Precision Oncology and Digitalization from Fundación CRIS Contra el Cáncer. VHIO would like to acknowledge the State Agency for Research (Agencia Estatal de Investigación) for the financial support as a Center of Excellence Severo Ochoa (CEX2020-001024-S/AEI/10.13039/501100011033), the Cellex Foundation for providing research facilities and equipment and the CERCA Program from the Generalitat de Catalunya for their support on this research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy

  • Zhao, Xuesong
  • Hao, Qianyun
  • Acosta, Daniel
  • Terán-Brage, Eduardo
  • Macarulla, Teresa
  • Alsina, Maria
  • Castet, Florian
  • Vega, kreina
  • Castro Boix, Sandra
  • TIAN, TIAN
Asia-West disparities; Chemotherapy; Gastric cancer, Disparidades entre Asia y Occidente; Quimioterapia; Cáncer gástrico, Disparitats entre Àsia i Occident; Quimioteràpia; Càncer gàstric, Gastric cancer (GC) remains a significant global health burden. Both Asian countries and Western nations, represented by Europe and North America, have long been pioneers in GC research and continue to lead advancements in the field. However, notable differences have historically existed between these regions in the treatment of resectable GC. In recent years, increasing convergence between Asian and Western approaches has emerged, driven by the growth of global collaborative studies. New definitive evidence suggests that the therapeutic landscape for resectable GC may undergo a significant transformation. In this review, we comprehensively examine the evolution of surgical approaches and perioperative chemotherapy strategies in Asia and the West. We summarize key clinical trials, highlight persistent survival disparities, and provide insight into current trends in perioperative management, including the recent advances in molecularly driven perioperative treatments. Finally, we outline key considerations for future multicenter perioperative trials to further guide global clinical practice., X.Z. is supported by grants from the Peking University People's Hospital (RDJP2024-20). T.V.T. is supported by grants from the Spanish Ministry of Science, Innovation, and Universities (PID2023-146827OB-I00), the “Ramon y Cajal” program (RYC2020-029098-I), and the FERO Foundation. T.M. is supported by grants from the Spanish Institute of Carlos III (PI20/00898, PI24/00526, FORT23/00034), EU TRANSCAN-3, and PerMed projects.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis

  • Conti, Sefora
  • Basagana, Míriam
  • Pando Rau, Elizabeth
  • Caritá, Lorenzo
  • Villacampa Javierre, Guillermo
  • Tissera, Natalia Soledad
  • Castet, Florian
  • Salcedo, Maria-Teresa
  • DOPAZO, CRISTINA
  • Navarro Garces, Victor
  • TIAN, TIAN
  • Macarulla, Teresa
Anatomic location; Cholangiocarcinoma; Disease-free survival, Localització anatòmica; Colangiocarcinoma; Supervivència lliure de malaltia, Localización anatómica; Colangiocarcinoma; Supervivencia libre de enfermedad, Background & Aims Cholangiocarcinoma (CCA), a heterogeneous malignancy that includes intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes, often exhibits perineural invasion (PNI). Despite PNI being associated with postoperative recurrence, evidence on its prognostic impact remains inconsistent. To clarify this, we conducted a systematic review and meta-analysis. Methods A comprehensive literature search was conducted across the Medline-PubMed, Embase, and Web of Science databases from their inception through February 27, 2025. We included studies involving patients diagnosed with CCA who underwent surgery and for whom PNI data were available. The primary outcomes were overall survival (OS) and disease-free survival (DFS), extracted from both univariable and multivariable analyses. The study is registered in PROSPERO (CRD42024575458). Results Of 1,555 articles screened, 64 retrospective studies comprising 15,543 patients were included. In the univariable analysis, the pooled hazard ratio (HR) for OS from 34 studies (6,084 patients) was 1.92 (95% CI 1.67-2.21, I2 = 59.6%). Multivariable-adjusted analysis of 42 studies (10,335 patients) showed an HR of 1.68 (95% CI 1.47-1.90, I2 = 47.9%) for patients with PNI. For DFS, the pooled univariable HR in 6,110 patients was 1.70 (95% CI 1.46-1.98, I2 = 52.3%), and the multivariable HR was 1.62 (95% CI 1.37-1.92, I2 = 70.5%)). Prognostic consistency was observed across anatomical subgroups. Univariable OS HRs were 2.14 for iCCA, 1.69 for pCCA, and 1.66 for dCCA. Corresponding multivariable HRs were 1.74, 1.60, and 1.66, respectively. Conclusions PNI is a prognostic factor for both DFS and OS in CCA, regardless of anatomical location. Further research is needed to elucidate its biological mechanisms and potential therapeutic implications. Impact and implications This comprehensive review and meta-analysis confirms that perineural invasion (PNI) predicts poorer overall and disease-free survival in cholangiocarcinoma, independent of tumor location. These results highlight the potential of PNI as a reliable histopathological marker to stratify postoperative risk and inform patient management. While most evidence is retrospective and smaller studies may overstate the effect, the consistent findings emphasize the need for large, multicenter prospective studies with standardized pathological assessment. Such efforts could facilitate the integration of PNI into prognostic models and support more individualized treatment strategies for patients with cholangiocarcinoma., S.C. is supported by a Juan de la Cierva Fellowship from the Spanish Ministry of Science, Innovation and Universities (JDC2023-050981-I). N.T. is supported by a La Pedrera MD-PhD fellowship from the Fundació Catalunya La Pedrera. T.M. is supported by grants from the Spanish Institute of Carlos III (PI20/00898, PI24/00526, FORT23/00034), EU TRANSCAN-3, and PerMed projects. T.V.T. is supported by grants from the Spanish Ministry of Science, Innovation and Universities (PID2023-146827OB-I00), “Ramon y Cajal” program (RYC2020-029098-I), FERO Foundation, Fundación AstraZeneca “Jóvenes Investigadores” program, and Cancer Core Europe TRYTRAC program.